Abilify Dosing for a 16-Year-Old
For a 16-year-old with schizophrenia, start aripiprazole at 2 mg/day, titrate to 5 mg after 2 days, then to the target dose of 10 mg/day after 2 additional days. 1
Indication-Specific Dosing
Schizophrenia (Most Common Indication)
- Starting dose: 2 mg/day 1
- Titration schedule: Increase to 5 mg after 2 days, then to 10 mg after 2 additional days 1
- Target dose: 10 mg/day 1
- Effective range: 10-30 mg/day, though doses above 10 mg/day have not demonstrated superior efficacy 1
- Maximum studied dose: 30 mg/day 1, 2
The FDA label specifically addresses adolescent schizophrenia (ages 13-17 years) with this graduated titration approach, which differs from the adult recommendation of starting directly at 10-15 mg/day 1. This slower titration in adolescents minimizes adverse effects while allowing time to assess tolerability 2.
Bipolar Mania
- Approved dose: 10 mg once daily for 12 weeks in adolescents ≥13 years 2
- The 30 mg/day dose showed no additional efficacy benefit over 10 mg/day and had worse tolerability 2
Autism-Related Irritability (Ages 6-17)
- Starting dose: 2 mg/day 3
- Target range: 5-15 mg/day 3
- Titration: Increase to 5 mg/day after 2 days, with further increases as needed 3
Weight-Based Considerations
- If weight >40 kg: Dose as adults (10-15 mg/day starting dose for most indications) 3
- If weight <40 kg: Use the pediatric titration schedule described above 3
At 16 years old, most patients will weigh >40 kg, but weight should still guide the decision between adult and pediatric dosing approaches 3.
Key Dosing Principles
Steady-State and Time to Effect
- Steady-state: Achieved by day 14 due to the 75-hour elimination half-life 1, 4
- Time to full effect: 1-4 weeks may be required before reaching maximum therapeutic benefit 4
- Minimum interval between dose increases: 2 weeks to allow for steady-state achievement 1
Optimal Dose Range
- Most effective dose: 10 mg/day shows the highest response rate in schizophrenia 5
- Threshold for clinical effect: Between 5-10 mg/day 5
- Doses >20 mg/day: Provide no additional benefit and may be associated with smaller symptom improvement 5
Important Caveats
Tolerability in Adolescents
- Younger patients (10-12 years) show less favorable tolerability than older adolescents (≥13 years) 2
- Lower doses (10 mg/day) are better tolerated than higher doses (30 mg/day) in this age group 2
- Common adverse effects include sedation, weight gain, and extrapyramidal symptoms (EPS), though EPS incidence at 10 mg/day is similar to placebo 2, 6
Dose Adjustments for Drug Interactions
- With strong CYP3A4 or CYP2D6 inhibitors: Reduce dose to 50% of usual dose 1
- With both CYP3A4 and CYP2D6 inhibitors: Reduce to 25% of usual dose 1
- With strong CYP3A4 inducers: Double the usual dose 1
- CYP2D6 poor metabolizers: Reduce dose to 50% of usual dose 1